The pharmaceutical industry and the production of regulatory knowledge - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2019

The pharmaceutical industry and the production of regulatory knowledge

Résumé

Regulatory knowledge, as the ensemble of experiences, information, data or simulations that constitute regulatory objects, or qualify medicines for regulatory intervention, come from a potentially diverse set of fields - from the pharmaceutical industry itself to the product testing industry, through academic or regulatory science centers and to a lesser extent health professionals and patients. The talk will outline a framework to analyze the relative weight of the actors pertaining to these fields in the selection of regulatory knowledge, and the dependence of public experts on privately produced regulatory knowledge.
Fichier non déposé

Dates et versions

hal-03300373 , version 1 (27-07-2021)

Identifiants

  • HAL Id : hal-03300373 , version 1

Citer

David Demortain. The pharmaceutical industry and the production of regulatory knowledge. Corporate Interests and Public Health Knowledge, Expertise, Markets. Final conference of the MEDICI project (2017-2019) on conflicts of interest in the field of medicines, Dec 2019, Saint-Denis, France. ⟨hal-03300373⟩
35 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More